GFAP and neoplasm: As expected, double immunostain combining GFAP and EBF3 showed a selective EBF3 expression in the GFAP-negative MB tumor component (Fig. 3D), suggesting co-existence of two different major tumor subclones with either glial or early neuronal differentiation.